Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Shinichiro Shimizu"'
Autor:
Tetsuo Fujita, Nami Hayama, Tsuguko Kuroki, Yuka Shiraishi, Hiroyuki Amano, Makoto Nakamura, Satoshi Hirano, Nao Aramaki, Shuji Ichinose, Shinichiro Shimizu, Hiroshi Tabeta, Sukeyuki Nakamura
Publikováno v:
Thoracic Cancer, Vol 10, Iss 11, Pp 2179-2182 (2019)
The safety of treatment with immune‐checkpoint inhibitors prior to thoracic surgery in patients with non‐small cell lung cancer (NSCLC) remains unclear. Here, we describe the case of a 62‐year‐old woman with NSCLC with programmed death ligand
Externí odkaz:
https://doaj.org/article/f9e3b252545f479a9f0a72c5574f0bcb
Autor:
Asako Yanagisawa, Satoshi Hirano, Shinichiro Shimizu, Takuma Hiroishi, Kohei Shikano, Noriko Hayama, Tetsuo Fujita, Hiroyuki Amano, Makoto Nakamura, Sukeyuki Nakamura, Hiroshi Tabeta
Publikováno v:
Case Reports in Oncological Medicine, Vol 2017 (2017)
We present a case of metastatic recurrence of carcinoid tumor accompanied by carcinoid syndrome in a 68-year-old Japanese man, 12 years after resection of typical pulmonary carcinoid. Histopathologic examination from percutaneous liver biopsy reveale
Externí odkaz:
https://doaj.org/article/402f9963546b4a8da0c315858f1677d4
Publikováno v:
Progress of Digestive Endoscopy. 100:127-129
Autor:
Yasuni Nakanuma, Katsuhiko Uesaka, Hiroko Ikeda, Shinichiro Shimizu, Susumu Matsukuma, Yasunori Sato, Jang Kee Taek, Yuko Kakuda, Kenichi Harada, Yukie Fukumura, Takuro Terada, Young Nyun Park, Takashi Sugino
Publikováno v:
Journal of Hepato-Biliary-Pancreatic Sciences. 27:402-413
Background and aims Intraductal papillary neoplasms of bile duct (IPNBs) remain a challenging entity to manage. Methods The pathologic spectrum of 34 gastric subtype of IPNB (gIPNB) cases was examined in consideration of the type 1 and 2 subclassific
Autor:
Yayoi Sato, Osamu Kainuma, Takashi Maruyama, Hajime Tanaka, Toshiyuki Natsume, Akinari Miyazaki, Hiromasa Note, Yasunari Matsumoto, Soichiro Hirasawa, Naoki Kuwayama, Shinichiro Shimizu, Akitoshi Kobayashi, Seiko Togo
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 53:344-351
Autor:
Tsuguko Kuroki, Hiroyuki Amano, Satoshi Hirano, Yuka Shiraishi, Sukeyuki Nakamura, Hiroshi Tabeta, Nami Hayama, Makoto Nakamura, Tetsuo Fujita, Shinichiro Shimizu
Publikováno v:
Journal of Thoracic Oncology. 15:e20-e22
Autor:
Nao Aramaki, Shuji Ichinose, Nami Hayama, Shinichiro Shimizu, Satoshi Hirano, Makoto Nakamura, Tetsuo Fujita, Hiroshi Tabeta, Hiroyuki Amano, Tsuguko Kuroki, Sukeyuki Nakamura, Yuka Shiraishi
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 10, Iss 11, Pp 2179-2182 (2019)
Thoracic Cancer, Vol 10, Iss 11, Pp 2179-2182 (2019)
The safety of treatment with immune‐checkpoint inhibitors prior to thoracic surgery in patients with non‐small cell lung cancer (NSCLC) remains unclear. Here, we describe the case of a 62‐year‐old woman with NSCLC with programmed death ligand
Autor:
Toshiyuki Natsume, Takashi Maruyama, Shinichiro Shimizu, Akitoshi Kobayashi, Hideaki Mizumoto
Publikováno v:
Progress of Digestive Endoscopy. 91:85-89
Autor:
Naoki, Kuwayama, Toshiyuki, Natsume, Osamu, Kainuma, Takashi, Maruyama, Hajime, Tanaka, Akinari, Miyazaki, Yayoi, Sato, Hiromasa, Note, Takafumi, Yoshioka, Yasunori, Matsumoto, Keisuke, Suzuki, Manami, Kato, Sumire, Oshima, Asuka, Ishigaki, Hideaki, Mizumoto, Shinichiro, Shimizu
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 46(4)
Combination therapy containingnab -paclitaxel(nab-PTX)and gemcitabine(GEM)is widely administered for metastatic pancreatic cancer. Recently, this regimen is likely to be applied for treatment in patients with locally advanced disease or for neoadjuva
Autor:
Kohei Shikano, Takuma Hiroishi, Noriko Hayama, Makoto Nakamura, Satoshi Hirano, Tetsuo Fujita, Sukeyuki Nakamura, Shinichiro Shimizu, Asako Yanagisawa, Hiroyuki Amano, Hiroshi Tabeta
Publikováno v:
Case Reports in Oncological Medicine
Case Reports in Oncological Medicine, Vol 2017 (2017)
Case Reports in Oncological Medicine, Vol 2017 (2017)
We present a case of metastatic recurrence of carcinoid tumor accompanied by carcinoid syndrome in a 68-year-old Japanese man, 12 years after resection of typical pulmonary carcinoid. Histopathologic examination from percutaneous liver biopsy reveale